| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
info@bocsci.com |
| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
3,4-Dihydroxy hydrocinnamic acid (L-aspartic acid dibenzyl ester) amide manufacturers
- CAY10485
-
- $127.00
-
2026-04-22
- CAS:615264-62-5
- Purity:
- Supply Ability: 10g
|
| | 3,4-Dihydroxy hydrocinnamic acid (L-aspartic acid dibenzyl ester) amide Basic information |
| | 3,4-Dihydroxy hydrocinnamic acid (L-aspartic acid dibenzyl ester) amide Chemical Properties |
| Boiling point | 727.6±60.0 °C(Predicted) | | density | 1.292±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF: 20 mg/ml; DMSO: 20 mg/ml; Ethanol: 20 mg/ml; Ethanol:PBS (pH 7.2)(1:3): .25 mg/ml | | form | A crystalline solid | | pka | 9.77±0.10(Predicted) |
| | 3,4-Dihydroxy hydrocinnamic acid (L-aspartic acid dibenzyl ester) amide Usage And Synthesis |
| Uses | LDL-IN-4 (Compound 2) inhibits human acyl-CoA:cholesterol acyltransferase-1 and -2 activities. LDL-IN-4 inhibits copper-mediated low density lipoprotein (LDL) oxidation, with an IC50 of 3 μM. LDL-IN-4 has anti-atherosclerotic biological activity[1]. | | References | [1] Lee S, et al. Synthesis of cinnamic acid derivatives and their inhibitory effects on LDL-oxidation, acyl-CoA:cholesterol acyltransferase-1 and -2 activity, and decrease of HDL-particle size. Bioorg Med Chem Lett. 2004 Sep 20;14(18):4677-81. DOI:10.1016/j.bmcl.2004.06.101 |
| | 3,4-Dihydroxy hydrocinnamic acid (L-aspartic acid dibenzyl ester) amide Preparation Products And Raw materials |
|